SleepCogni puts the power of a good night’s sleep in your hands. Using clinically tested, patented technology; combining a handheld device with a SaaS platform, users can control their wind down process by collecting physiological, behavioural & environmental data. We're fundraising to commercialise the product.
1 in 3 people experience sleep challenges at some point in their lives. Apart from medication, we feel the market offering only focuses on monitoring sleep, rather than the process of getting to sleep.
- One study suggests 38% of sufferers reported insomnia for 5+ years
- 1m people in the UK take sleeping pills for insomnia
- 70% of people have had new sleep challenges since COVID-19
SleepCogni focuses on the pathway to sleep; helping users control their wind down process with patented, award-winning technology. Our device receives data from 15 different sensors, providing detailed & informative insights into the person’s sleep struggle that are used for clinical intervention including CBT-I (cognitive behavioural therapy for insomnia). SleepCogni's haptic feedback is designed to break cognitive cycles that prevent sleep.
We'll initially target sleep clinics in the UK & US (US sleep clinic market in 2020 = $9bn). We'll then expand into other countries by also targeting health insurers. We have 11 granted & 4 pending patents in various territories, a trademark on the logo & protection of specific handheld trigger hardware.
Having found our niche in the sleep healthcare market, we're now fundraising to commercialise the product. Invest in SleepCogni and put the power of a good night’s sleep back in people's hands.